Gilead Sciences signed joint procurement agreement with European Commission for Vekluryﾮ (remdesivir)
On Oct. 8, 2020, Gilead Sciences and the European Commission signed a joint procurement agreement (JPA) that enabled…
Gilead Sciences updated supply and distribution of Vekluryﾮ (remdesivir) in the US
On Oct. 8, 2020, The New England Journal of Medicine (NEJM) published the final results from the National…
Emergent BioSolutionsﾒ COVID-19 product candidate included in NIH-sponsored phase 3 clinical trial
On Oct. 8, 2020, Emergent BioSolutions announced the initiation of the Phase 3 clinical trial that will evaluate…
Baricitinib had significant effect on recovery time, most Impactful in COVID-19 patients requiring oxygen
On Oct. 8, 2020, Eli Lilly and Incyte shared additional data showing baricitinib in combination with remdesivir reduced…
Yale Cancer Center received NIH grant to fund COVID-19 research in patients with hematologic cancers
On Oct. 8, 2020, the National Institutes of Health (NIH) awarded a Research Project Cooperative Agreement grant to…
Johnson & Johnson announced EC approval of agreement to supply 200 million doses of COVID-19 vaccine candidate
On Oct. 8, 2020, Johnson & Johnson announced the European Commission, acting on behalf of the European Union…
Caladrius Biosciences opened study of CLBS119 to repair COVID-19-induced lung damage
On Oct. 8, 2020, Caladrius Biosciences announced that it had opened its proof-of-concept study of CLBS119 as a…
Rentschler Biopharma contributed to manufacturing of COVID-19 mRNA vaccine
On Oct. 7, 2020, Rentschler Biopharma announced an agreement to serve as CDMO partner for BioNTech. As an…
Kindred Biosciences announced expansion of Manufacturing agreement with Vaxart for COVID-19 and other vaccine candidates
On Oct. 7, 2020, Kindred Biosciences announced it had expanded an agreement with Vaxart for the manufacture of…
Lilly updated progress of SARS-CoV-2 neutralizing antibody programs
On Oct. 7, 2020, Eli Lilly announced additional details on its SARS-CoV-2 neutralizing antibody programs ﾖ including interim…
Chemicals similar to those found in cannabis can inhibit bacterial virulence
On Oct. 7, 2020, UT Southwestern scientists showed that endocannabinoids, signaling molecules produced in the body that share…
NIH supported 85 new grants featuring high-risk, high-reward research
On Oct. 6, 2020, the NIH announced it had awarded 85 grants through its High-Risk, High-Reward Research (HRHR)…
SARS-CoV-2 may use key carbohydrate to infect cells
On Oct. 6, 2020, NIH researchers announced they had found that a carbohydrate called heparan sulfate, which is…
HHS funded development of needle-free vaccine administration technology
On Oct. 6, 2020, the U.S. Department of Health and Human Services announced funding of a patch that…
Andrea Ghez won a share of the Nobel Prize in Physics for the discovery of a supermassive compact object at the center of our galaxy (black hole).
On Oct. 6, 2020, the Nobel Foundation announced that Andrea Ghez had won a share of the Nobel…
FDA broadly supported Oragenicsﾒ pre-IND development program for its SARS-CoV-2 vaccine
On Oct. 6, 2020, Oragenics announced receipt of feedback to its Type B Pre-IND Meeting Request from the…
AIM ImmunoTech announced approval to enroll COVID-19 ‘long haulers’ in AMP-511 ME/CFS clinical trial of Ampligen
On Oct. 6, 2020, AIM ImmunoTech announced that it had received Institutional Review Board approval for the expansion…
FDA amended EUA for Hologicﾒs Aptima SARS-CoV-2 assay to Include COVID-19 testing of asymptomatic individuals
On Oct. 6, 2020, Hologic announced that its Aptimaﾮ SARS-CoV-2 assay, which initially received Emergency Use Authorization (EUA)…
BioNTech and Pfizer initiated a rolling submission to EMA for SARS-CoV-2 vaccine candidate BNT162b2
On Oct. 6, 2020, Pfizer and BioNTech announced initiation of a rolling submission to the European Medicines Agency…
FDA awarded contract to Stanford University to perform in-depth analysis of tissue samples to learn how SARS-CoV-2 causes COVID-19
On Oct. 5, 2020, the FDA awarded a research contract to the Stanford University School of Medicine to…
CLEAR adds LabCorp COVID-19 test results to ﾓHealth Passﾔ mobile app
On Oct. 5, 2020, CLEAR, the secure identity company, and LabCorp announced a partnership to enable users of…
CLEAR and Quest Diagnostics collaborated to integrate COVID-19 test results with “Health Pass” for safer environments
On Oct. 5, 2020, CLEAR, the secure identity company, and Quest Diagnostics announced a new collaboration that aimed…
Bristol Myers Squibb to acquire MyoKardia for $131 billion in cash
On Oct. 5, 2020, Bristol-Myers and MyoKardia announced a definitive merger agreement under which Bristol Myers Squibb will…
NIH awarded $138 million for studies on the prevention and treatment of Alzheimer’s disease
On Oct. 5, 2020, Joe Verghese, M.B.B.S., M.S., an international leader in aging and cognition research at Albert…
The Nobel Prize in Chemistry for 2021 was awarded to Benjamin List and David MacMillan
On Oct. 5, 2021, the Nobel Prize in Chemistry 2020 was awarded to Benjamin List and David MacMillan…
FDA approved drug combination for treating mesothelioma
On Oct. 1, 2020, the FDA approved Opdivo (nivolumab) in combination with Yervoy (ipilimumab) for the first-line treatment…
COVID-19 vaccine AZD1222 clinical trial resumed in Japan, follows restart of trials in the UK, Brazil, South Africa and India
On Oct. 2, 2020, AstraZeneca announced the phase I/II clinical trial for the COVID-19 vaccine AZD1222 had resumed…
National Science Foundation announced investment of $40 million in future of US manufacturing
On Oct. 2, 2020, the National Science Foundation announced investments in 24 new projects to drive future manufacturing….
Humanigen announced COVID-19 case report demonstrated rapid resolution after single IND EUA of Lenzilumabﾙ
On Oct. 2, 2020, Humanigen announced that a patient case report on the use of lenzilumabﾙ in critical…
UConn funded five COVID-19 research projects, announced additional funding
On Oct. 2, 2020, the Uconn Office of the Vice President for Research (OVPR) (OVPR) announced a new…